Medpace Holdings, Inc.
MEDP • NASDAQ
Medpace Holdings, Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO August James Troendle, with a market cap of $12.8B.
CEOAugust James Troendle
Next Earnings
Upcoming earnings announcement for Medpace Holdings, Inc.
Date
Wednesday, April 22, 2026 (in 3 weeks)
Timing
After Market Close (4:15 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
$3.90
Revenue Estimate
$696.5M
Earnings History
Past 12 earnings reports for Medpace Holdings, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 9, 2026 | Q4 2025 | $4.67Est: $4.21 | +10.9% | $708.5MEst: $687.0M | +3.1% |  10-K |
| Oct 22, 2025 | Q3 2025 | $3.86Est: $3.54 | +9.0% | $659.9MEst: $640.8M | +3.0% | — |
| Jul 21, 2025 | Q2 2025 | $3.10Est: $2.99 | +3.7% | $603.3MEst: $539.3M | +11.9% | 10-Q |
| Apr 21, 2025 | Q1 2025 | $3.67Est: $3.08 | +19.2% | $558.6MEst: $527.2M | +6.0% | 10-Q |
| Feb 10, 2025 | Q4 2024 | $3.67Est: $3.12 | +17.6% | $536.6MEst: $535.0M | +0.3% | 10-K |
| Oct 21, 2024 | Q3 2024 | $3.01Est: $2.78 | +8.3% | $533.3MEst: $541.0M | -1.4% | 10-Q |
| Jul 22, 2024 | Q2 2024 | $2.75Est: $2.54 | +8.3% | $528.1MEst: $528.4M | -0.1% | 10-Q |
| Apr 22, 2024 | Q1 2024 | $3.20Est: $2.46 | +30.1% | $511.0MEst: $512.6M | -0.3% | 10-Q |
| Feb 12, 2024 | Q4 2023 | $2.46Est: $2.22 | +10.8% | $498.4MEst: $498.7M | -0.1% | 10-K |
| Oct 23, 2023 | Q3 2023 | $2.22Est: $2.04 | +8.8% | $492.5MEst: $475.8M | +3.5% | 10-Q |
| Jul 24, 2023 | Q2 2023 | $1.93Est: $1.91 | +1.0% | $460.9MEst: $433.7M | +6.3% | 10-Q |
| Apr 24, 2023 | Q1 2023 | $2.27Est: $1.80 | +26.1% | $434.1MEst: $401.8M | +8.0% | — |